Nextblockbuster

I am still here for the same reasons. Hoping that Covid trial is a success and apabetalone is granted EUA. Waiting for the 2021 financial statements and resolution of the debenture and operating capital. The insiders have the same choices that we have and right now they are under water and holding. Imo Ori is a key element for future financing - although a HEPA takeover is bothersome. We need a BP partner. Not sure why they have not stepped up - but it may have something to do with HEPAs large position and the Royalty Preferred Shares.